Clinical Guides
Deep Vein Thrombosis
A clinically focused guide to suspected and confirmed deep vein thrombosis in Indian practice, covering pretest probability, D-dimer and ultrasound pathways, anticoagulant and bleeding decisions, pregnancy, cancer, renal impairment, limb-threatening iliac disease and recurrence prevention.
MedNext Academy | 13 min read
Deep Vein Thrombosis
A clinically focused guide to suspected and confirmed deep vein thrombosis in Indian practice, covering pretest probability, D-dimer and ultrasound pathways, anticoagulant and bleeding decisions, pregnancy, cancer, renal impairment, limb-threatening iliac disease and recurrence prevention.
Summary
Deep vein thrombosis is thrombus in the deep venous system, most often in a lower limb, with risks of pulmonary embolism, recurrence and post-thrombotic symptoms. Clinical appearance alone is unreliable: pain and swelling have many alternatives, while some proximal thromboses are subtle. The safe sequence is to assess physiological stability and pulmonary-embolism symptoms, estimate pretest probability with a validated pathway, use D-dimer only where it can change the next step, and obtain compression ultrasonography without avoidable delay.
The two-level DVT Wells score structures probability but does not diagnose or exclude DVT by itself. A likely score leads to proximal-leg-vein ultrasound, with D-dimer and repeat imaging determined by the result and pathway. An unlikely score generally leads first to a sensitive D-dimer. If indicated imaging is delayed, guideline-directed interim therapeutic anticoagulation may be required after bleeding and contraindication assessment. Pregnancy, puerperium and some cancer pathways need specialist adaptation; uncritical application of Wells or age-adjusted D-dimer is unsafe where validation is inadequate.
Confirmed proximal DVT is treated with anticoagulation unless contraindicated. Agent, dose and setting depend on renal and hepatic function, pregnancy, cancer, antiphospholipid syndrome, weight, bleeding, interactions, adherence, price and availability. Thrombolysis is not routine; limb-threatening phlegmasia and selected symptomatic iliofemoral disease need urgent vascular expertise. Treatment duration depends on whether the event was provoked, persistent-risk or unprovoked, with reassessment of recurrence against bleeding. This draft is educational and quarantined following MedNext Clinical Team review.
How Common Is It?
Venous thromboembolism includes DVT and pulmonary embolism and is a common vascular disorder worldwide. Published incidence varies substantially by population age, case ascertainment, inpatient exposure and access to diagnostic imaging. Indian hospital series cannot be treated as national community incidence, and absence of a single surveillance figure should not be mistaken for rarity. Ageing, cancer care, major surgery, obstetric complications and immobility all create a continuing clinical burden.
Risk is concentrated around exposures. A person after major lower-limb surgery has a different short-term probability from an ambulatory adult with mild calf discomfort. Hospital-associated VTE may appear during admission or after discharge. Pregnancy-related risk extends into the puerperium, and cancer-associated thrombosis may precede diagnosis, complicate active treatment or recur. Distal calf DVT and proximal femoral or iliac DVT differ in embolic and post-thrombotic consequences, so a prevalence statement without anatomical definition is incomplete.
The practical epidemiology is therefore case-finding: recognize high-risk settings, avoid diagnosing solely from symptoms, and maintain access to timely ultrasound and anticoagulation. Services should audit time from presentation to imaging, use of interim anticoagulation, confirmed anatomical extent, major bleeding, recurrence and loss to follow-up. In resource-variable Indian settings, apparent low incidence may reflect failure to image, while indiscriminate D-dimer testing can produce over-investigation. Neither assumption improves care. Individual probability comes from the current presentation and validated diagnostic pathway, not a population headline.
Risk Factors
Virchow's triad organizes risk: venous stasis, endothelial injury and hypercoagulability. Major transient factors include recent surgery or trauma, hospitalisation, plaster immobilisation, prolonged marked immobility and pregnancy or puerperium. Oestrogen-containing contraception and hormone therapy increase risk. Active cancer, especially with systemic treatment or central venous access, is a major persistent factor. Previous VTE is one of the strongest predictors of another event.
Other contributors include increasing age, obesity, inherited or acquired thrombophilia, antiphospholipid syndrome, inflammatory disease, nephrotic syndrome, myeloproliferative disease, heart failure, severe infection and neurological paralysis. Long travel may contribute when combined with immobility and other factors, but it should not be used to explain every unprovoked event. Ask about anatomical compression, such as left iliac-vein obstruction, when extensive unilateral disease occurs, and about upper-limb devices when symptoms involve an arm.
The distinction between provoked and unprovoked determines recurrence discussion but should be documented precisely. A major transient factor that has resolved differs from active cancer, a persistent inflammatory disorder or a weak association such as a journey. Do not order broad inherited thrombophilia panels during acute thrombosis or while anticoagulated without a question that would change management. Family history, unusual site, young age and recurrence may justify haematology input. Absence of a recognised factor does not prove occult cancer or a genetic disorder; it signals structured history, examination, basic investigation and later duration review.
Diagnosis
History
Establish onset, progression, laterality and distribution of pain or swelling. Ask about recent operation, trauma, admission, immobility, cast, long journey, pregnancy or postpartum status, oestrogen exposure, active cancer and treatment, prior VTE, family history, infection, bleeding and current antithrombotics. Chest pain, breathlessness, haemoptysis, syncope or unexplained hypoxaemia requires concurrent pulmonary-embolism assessment. Severe whole-limb swelling, cyanosis, sensory change or escalating pain suggests threatened venous outflow.
Examination
Record observations and cardiopulmonary status first. Compare both limbs for swelling, pitting oedema, tenderness along the deep venous distribution, collateral superficial veins and measured calf circumference using a reproducible point. Look for cellulitis, injury, joint disease, varicosities, lymphoedema and arterial compromise. Palpable pulses do not exclude DVT. Calculate the two-level Wells score explicitly, including alternative diagnosis at least as likely; a score is invalid if components are guessed or copied forward.
Investigations
In the current pathway, a likely Wells score prompts proximal-leg-vein ultrasound rapidly. If negative, perform D-dimer and, when D-dimer is positive, repeat ultrasound after the specified interval. An unlikely score prompts D-dimer first; a positive result leads to ultrasound. Consider an age-adjusted threshold in people over 50 only where the assay and local pathway support it. If timely testing is unavailable, assess baseline blood count, renal and hepatic function, coagulation screen and pregnancy status where relevant, then follow the interim-anticoagulation pathway. Persistent suspicion of iliac thrombosis despite negative standard compression imaging requires specialist whole-leg or pelvic imaging rather than repeated reassurance.
Differential Diagnosis
Unilateral leg swelling may reflect cellulitis, ruptured Baker cyst, muscle tear or haematoma, superficial venous thrombosis, chronic venous insufficiency, lymphoedema, joint effusion, fracture, compartment syndrome or external venous compression. Bilateral oedema is more often systemic, including heart, kidney or liver disease, medicines or dependent oedema, although bilateral DVT can occur. Pain out of proportion, neurological deficit or a tense compartment suggests a surgical emergency. An acutely cold, pale or pulseless limb is arterial until assessed otherwise.
Cellulitis favours warmth, erythema, skin tenderness and a portal of entry, but it can coexist with thrombosis. Superficial thrombophlebitis follows a palpable tender vein and may approach the deep system. A ruptured popliteal cyst can produce sudden calf pain and swelling. Haematoma is particularly important after trauma, procedure or anticoagulation. Lymphoedema often has chronic skin and tissue change, while venous insufficiency produces dependent symptoms and pigmentation.
If ultrasound is negative, interpret what was imaged. A standard proximal scan may not assess calf or iliac veins, and early thrombosis can require serial imaging according to the diagnostic algorithm. Conversely, residual non-compressibility after previous DVT does not automatically prove acute recurrence; compare prior imaging and look for new segments or change. In pregnancy, left-sided iliac disease may present with whole-leg or back symptoms and require additional imaging. The differential diagnosis is not a reason to omit objective testing when probability remains meaningful.
Management
Begin anticoagulation promptly for objectively confirmed proximal DVT unless active major bleeding or another contraindication requires urgent specialist balancing. If diagnostic imaging is delayed beyond the pathway's time target, interim therapeutic anticoagulation may be appropriate after baseline tests and bleeding assessment; do not allow laboratory results to create an unsafe delay when the protocol supports treatment. Decide whether outpatient care is safe: uncomplicated DVT may be managed at home only when the person is stable, pain is controlled, medicine is obtainable, education is understood and follow-up is reliable.
For most adults without renal impairment, active cancer, triple-positive antiphospholipid syndrome or extreme weight, current guidelines recommends apixaban or rivaroxaban as options. Other regimens require parenteral lead-in or overlap. Choice must follow current product information and local formulary. Cancer, renal failure, pregnancy, liver disease, interacting medicines and affordability alter selection. Encourage tolerated walking after anticoagulation rather than routine bed rest, and give pulmonary-embolism and bleeding safety advice.
Anticoagulation alone is standard for most proximal DVT. Urgently involve vascular and interventional expertise for phlegmasia or limb threat. Catheter-directed thrombolysis may be considered only in carefully selected symptomatic iliofemoral DVT with low bleeding risk and appropriate functional prognosis; evidence is uncertain and bleeding is real. Inferior vena cava filters are not added routinely when anticoagulation is possible. Review treatment at about three months, or three to six months in active cancer, then decide whether to stop or continue based on provoking factor, recurrence and bleeding risk.
Prescribing Information
Anticoagulants are high-risk medicines. Before prescribing, document indication, anatomical diagnosis, weight, full blood count, platelet count, creatinine clearance using the method required for the drug, liver function, baseline coagulation testing, pregnancy status where relevant, active bleeding, recent neuraxial procedure, planned surgery, interacting medicines and ability to obtain the complete course. Estimated GFR displayed by a laboratory is not automatically interchangeable with Cockcroft-Gault creatinine clearance for direct oral anticoagulant dosing. Follow the current Indian label and local protocol for exact dose, lead-in, reduction and contraindications.
Apixaban and rivaroxaban use indication-specific initial treatment regimens; dabigatran and edoxaban require preceding parenteral anticoagulation for acute VTE. Warfarin requires heparin overlap until the INR is therapeutic and stable under a verified protocol. Low-molecular-weight heparin dosing is weight- and renal-dependent. Pregnancy generally requires specialist low-molecular-weight heparin management; direct oral anticoagulants are avoided, and delivery or neuraxial planning must be coordinated. Active cancer decisions include tumour site, gastrointestinal or genitourinary bleeding, thrombocytopenia, interactions, absorption, injections and patient preference.
Teach adherence, missed-dose instructions from the specific leaflet, bleeding signs, trauma response and disclosure before procedures or new medicines. Avoid NSAIDs and unnecessary antiplatelets; reconcile aspirin. Major bleeding requires resuscitation, source control, last-dose timing, renal function and drug-specific reversal pathways. Never improvise dose reduction to make treatment feel safer: underdosing risks recurrence while unmonitored full dosing risks haemorrhage. Arrange written duration, monitoring and renewal ownership.
When to Refer
Refer urgently to emergency or vascular services for phlegmasia cerulea dolens, threatened limb, severe whole-leg swelling with cyanosis, suspected iliac or caval thrombosis, compartment concerns, haemodynamic instability or concurrent suspected pulmonary embolism. A negative routine proximal scan with strong iliac features warrants further imaging rather than discharge from the pathway. Selected recent symptomatic iliofemoral DVT may merit rapid assessment for catheter-directed therapy, but routine calf or femoropopliteal DVT does not.
Seek specialist haematology, vascular medicine, oncology, nephrology or obstetric input for pregnancy or puerperium, active cancer, severe renal impairment, significant liver disease, thrombocytopenia, antiphospholipid syndrome, unusual-site or recurrent thrombosis, anticoagulant failure, major bleeding, extreme body weight, suspected heparin-induced thrombocytopenia or uncertainty about duration. Children and adolescents require paediatric expertise. Inferior vena cava filter decisions belong to a specialist pathway when anticoagulation is truly contraindicated, with a retrieval plan.
Routine referral is reasonable for persistent post-thrombotic symptoms, recurrent swelling, skin change or ulceration after the acute phase. Unprovoked DVT requires a structured review of history, examination and basic results; do not order indiscriminate advanced cancer imaging without indication, but refer abnormalities and ensure age-appropriate screening. In India, communicate exact anatomy, provoking factors, renal function, current dose, last dose, bleeding, affordability and follow-up capacity. A referral that omits anticoagulation continuity can itself cause harm.
Red Flags
Breathlessness, pleuritic or central chest pain, haemoptysis, syncope, hypotension, tachycardia with clinical concern, unexplained hypoxaemia or cardiac arrest may indicate pulmonary embolism. Assess and escalate immediately; a leg diagnosis does not define pulmonary severity. Severe swelling of the entire limb, cyanosis, venous gangrene, escalating pain, blistering, sensory or motor change indicates phlegmasia and possible limb threat. A cold pulseless limb suggests arterial compromise and also requires emergency vascular assessment.
Before and during anticoagulation, active major bleeding, haemodynamic compromise, falling haemoglobin, intracranial symptoms, gastrointestinal bleeding, heavy uncontrolled uterine bleeding, expanding haematoma or recent high-risk procedure demands urgent review. New thrombocytopenia after heparin exposure raises heparin-induced thrombocytopenia; do not simply continue heparin while awaiting routine follow-up. Renal deterioration can cause drug accumulation. A recurrent clot while apparently treated requires confirmation, adherence and interaction assessment, cancer or antiphospholipid review, and specialist management rather than empirical dose changes.
Pregnancy and the puerperium lower the threshold for objective assessment because symptoms overlap normal pregnancy and pulmonary embolism can be catastrophic. Severe back or groin pain with whole-leg swelling may indicate iliac thrombosis. A negative D-dimer or Wells score should not provide false reassurance outside a validated pregnancy pathway. System red flags include delayed ultrasound without an interim plan, no access to the prescribed anticoagulant, absent written duration, or no route to obtain urgent bleeding advice.
Indian Clinical Context
Indian DVT care spans tertiary vascular centres, medical colleges, district hospitals and smaller facilities where ultrasound, D-dimer assays, anti-Xa testing, reversal agents or interventional radiology may not be consistently available. The correct response to limited access is an explicit transfer and interim-treatment pathway, not reliance on Homans sign or prolonged empirical anticoagulation without objective diagnosis. Identify the nearest service able to perform compression ultrasound and the time to reach it.
Medicine availability and price influence safe choice. India's National List of Essential Medicines 2022 includes unfractionated heparin, low-molecular-weight heparin and warfarin, but local stock and monitoring capacity still need confirmation. Direct oral anticoagulants may simplify laboratory monitoring but can be unaffordable, have renal and interaction limitations, and require reliable uninterrupted supply. Warfarin is inexpensive but unsafe without accessible INR testing, dose communication and dietary and interaction counselling. Select a sustainable complete regimen rather than a few days of an idealized one.
international and ASH guidelines inform diagnostic and treatment principles but were not written as Indian national protocols. Local laboratories must validate D-dimer assays and thresholds; age adjustment requires an accepted pathway. Cancer and obstetric care should be coordinated with the treating teams, and neuraxial timing must never be improvised. Written advice should use the person's language and include pulmonary-embolism symptoms, bleeding response, missed doses, procedure disclosure and a named follow-up site. Transport, work loss and refill travel are clinical safety variables, not administrative details.
NMC Competency Mapping
DVT integrates NMC undergraduate competencies across General Medicine, Surgery, Obstetrics and Gynaecology, Pharmacology, Pathology and emergency care. The learner should take a focused venous-thromboembolism and bleeding history, examine both limbs systematically, assess cardiopulmonary stability and recognise pulmonary embolism or threatened venous outflow. Clinical reasoning includes using a pretest-probability tool correctly, understanding D-dimer sensitivity and specificity, and interpreting compression ultrasound within its anatomical limits.
Pharmacology outcomes include mechanisms and safety of heparins, vitamin K antagonists and direct oral anticoagulants; renal, hepatic and pregnancy constraints; interactions; monitoring; and reversal principles. Obstetric learning includes increased pregnancy and puerperal risk, objective diagnosis and coordinated low-molecular-weight heparin and delivery planning. Surgery contributes postoperative risk, limb threat, thrombectomy or catheter-directed concepts and compression or ulcer care. Pathology contributes Virchow's triad, inherited and acquired thrombophilia and heparin-induced thrombocytopenia.
Assessment can use a Wells-score station, an ultrasound-pathway viva, a prescription-safety check with creatinine clearance, an unprovoked-versus-provoked duration discussion and an emergency phlegmasia handover. The learner should explain why D-dimer is not a universal rule-out test, why routine thrombolysis and routine filters are avoided, and why compression stockings are not routinely prescribed solely to prevent post-thrombotic syndrome. Institutions should map these outcomes to the current CBME curriculum rather than reproducing an unverified secondary code list. This guide does not certify independent anticoagulant prescribing.
Key Exam Pearls for NEET PG
Virchow's triad is stasis, endothelial injury and hypercoagulability. The two-level DVT Wells score assigns points for active cancer, paralysis or immobilisation, recent bed rest or major surgery, tenderness along deep veins, entire-leg swelling, calf swelling, unilateral pitting oedema, collateral superficial veins and previous DVT; an alternative diagnosis at least as likely subtracts points. A score of two or more is DVT likely in the current pathway, but the score directs testing and is not the diagnosis.
A likely score leads to proximal compression ultrasound. If initial ultrasound is negative and D-dimer positive, repeat proximal imaging after six to eight days in the current guidelines algorithm. An unlikely score leads first to D-dimer; a negative sensitive result excludes DVT within that pathway. D-dimer rises with age, pregnancy, cancer, inflammation, surgery and hospitalisation, so a positive result is non-specific. Ultrasound detects non-compressibility; iliac disease may require additional imaging.
Treat most confirmed proximal DVT with anticoagulation alone. Direct oral anticoagulants are not interchangeable across lead-in schedules and are constrained by renal function, antiphospholipid syndrome, pregnancy and other factors. Anticoagulation is reviewed after at least three months, with duration determined by provoking factor, recurrence and bleeding. Thrombolysis is reserved for limb-threatening phlegmasia or selected iliofemoral disease. Inferior vena cava filters are not routine if anticoagulation is possible. Graduated compression stockings are not routinely offered solely to prevent post-thrombotic syndrome, though they may be used for symptom management.
Frequently Asked Questions
Can a negative D-dimer always exclude deep vein thrombosis?
No. It excludes DVT only when used with an appropriate validated pretest-probability pathway, a sufficiently sensitive assay and the correct threshold. Anticoagulation, delayed presentation and special populations can alter interpretation. A person with a DVT-likely score generally needs ultrasound, and pregnancy requires a specialist objective-testing pathway.
Does a normal first leg ultrasound always end the investigation?
No. It depends on pretest probability, D-dimer, anatomy examined and symptom pattern. Current guidelines recommends repeat proximal ultrasound six to eight days later when the first scan is negative but D-dimer is positive in the likely pathway. Suspected iliac thrombosis may require pelvic or whole-leg imaging even when routine proximal compression is negative.
How long is anticoagulation continued after a confirmed deep vein thrombosis?
Treat confirmed proximal DVT for at least three months, then reassess. A resolved major transient provoking factor may support stopping when the course is uncomplicated; active cancer is reviewed at three to six months, and unprovoked, persistent-risk or recurrent events may favour extended therapy. The decision repeatedly balances recurrence against bleeding and patient preference.
Are compression stockings and thrombolysis routine treatment for proximal deep vein thrombosis?
No. Anticoagulation is standard for most patients. Stockings are not routinely offered solely to prevent post-thrombotic syndrome, although they can help selected symptoms. Thrombolysis adds bleeding risk and is reserved for limb-threatening phlegmasia or carefully selected recent symptomatic iliofemoral DVT after specialist assessment and shared discussion of uncertain benefit.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic